Why is Kerala Ayurveda Ltd falling/rising?

Jan 10 2026 01:06 AM IST
share
Share Via
As of 09-Jan, Kerala Ayurveda Ltd’s stock price has declined by 0.71% to ₹316.50, continuing a recent downward trend driven by deteriorating financial performance and weakening investor confidence.




Recent Price Movement and Market Context


Kerala Ayurveda’s shares have been under pressure, falling for two consecutive days with a cumulative decline of 2.16%. The stock touched an intraday low of ₹308.15, down 3.33% from previous levels, and traded closer to its 52-week low of ₹301.35, currently just 4.79% away. Notably, the weighted average price indicates that a larger volume of shares exchanged hands near the lower price range, signalling selling pressure. The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically suggests a bearish trend.


Despite these challenges, Kerala Ayurveda has marginally outperformed its sector today by 0.26%, and its year-to-date return stands positive at 0.24%, outperforming the Sensex’s negative 1.93% over the same period. However, the stock’s longer-term performance remains weak, with a one-year return of -21.85%, significantly underperforming the Sensex’s 7.67% gain and the broader BSE500’s 6.14% rise.



Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!



  • - Expert-scrutinized selection

  • - Already delivering results

  • - Monthly focused approach



Get Next Month's Pick →



Fundamental Weaknesses Weighing on the Stock


The primary reason behind Kerala Ayurveda’s share price decline is its weak fundamental profile. The company carries a high debt burden, with a debt-to-equity ratio of 14.59 times, indicating significant leverage that raises financial risk. This high debt level undermines the company’s long-term fundamental strength and investor confidence.


Operating profit growth has stagnated over the past five years, registering an annual growth rate of 0%, which points to a lack of expansion or improvement in core profitability. Furthermore, the company’s return on capital employed (ROCE) averages just 6.09%, reflecting low efficiency in generating profits from its capital base. The most recent half-year ROCE plunged to a negative 15.13%, signalling deteriorating operational performance.


Kerala Ayurveda has reported negative results for three consecutive quarters. Its profit before tax excluding other income (PBT less OI) fell sharply by 64.6% to a loss of ₹8.52 crore compared to the previous four-quarter average. Net profit after tax (PAT) plunged by 94.8% to a loss of ₹6.34 crore, underscoring the company’s ongoing struggles to return to profitability. These losses have contributed to a negative EBITDA, which further increases the risk profile of the stock.


Investor Sentiment and Promoter Actions


Investor participation has also declined, with delivery volumes on 08 Jan dropping by 51.74% compared to the five-day average, indicating reduced buying interest. This diminished investor engagement often precedes further price weakness.


Adding to concerns, promoters have reduced their stake by 4.69% over the previous quarter, now holding 33.14% of the company. Such a reduction in promoter holding can be interpreted as a lack of confidence in the company’s near-term prospects, which may further dampen market sentiment.


Given these factors, Kerala Ayurveda’s stock has underperformed the market significantly over the past year, generating negative returns of 21.85% while the broader market indices have posted gains. This divergence highlights the challenges the company faces in regaining investor trust and improving financial performance.



Is Kerala Ayurveda your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!



  • - Better alternatives suggested

  • - Cross-sector comparison

  • - Portfolio optimization tool



Find Better Alternatives →



Outlook and Investor Considerations


While Kerala Ayurveda has demonstrated impressive long-term returns over three and five years, with gains of 216.82% and 476.50% respectively, the recent financial setbacks and high leverage pose significant risks. The stock’s current trading below all major moving averages and proximity to its 52-week low suggest that investors remain cautious.


For investors, the key considerations include the company’s ability to reduce debt, return to profitability, and restore promoter confidence. Until these fundamental issues are addressed, the stock is likely to remain under pressure despite occasional short-term outperformance relative to its sector.


In summary, Kerala Ayurveda Ltd’s recent share price decline is primarily driven by weak financial results, high debt levels, falling profitability, and reduced promoter stake, all of which have contributed to subdued investor sentiment and lower trading volumes.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News